Harrow Health (HROW) Tops Q4 EPS by 19c

Harrow Health (NASDAQ: HROW) reported Q4 EPS of $0.07, $0.19 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $21.4 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79